![]() ![]() The pharmaceutical value chain is composed of a number of key activities: drug discovery and development to identify promising pharmacological candidates, clinical trials to ensure the safety and effectiveness of these drugs in humans, and mass production of approved drugs. And for China, the influx of investment is an important stepping stone to fulfilling its long-held desires to create a robust domestic pharmaceutical industry. For Big Pharma, there’s the chance to cut costs and expand into a wealthy, populous market. Like any good relationship, the burgeoning love affair between China and the relatively small number of global companies known as ‘Big Pharma’ offers promise for both parties. ![]() But its global ambitions might turn the industry upside down. China’s muscling into the pharmaceutical industry, helping Big Pharma bite back against generics.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |